Role of Biomarkers in Screening and Diagnosis of Ovarian Cancer

Role of Biomarkers in Screening and Diagnosis of Ovarian Cancer

The overall mortality of ovarian cancer exceeds that of other gynecologic cancers owing to lack of disease-specific symptoms. Three quarters of patients with ovarian cancer are diagnosed after the disease has progressed to advanced stage. Thus, improvement of an effective screening tool could resu...

Full description

Bibliographic Details
Main Author:	Yenrudee Poomtavorn
Format:	Article
Language:	English
Published:	The Royal Thai College of Obstetricians and Gynaecologists 2016-12-01
Series:	Thai Journal of Obstetrics and Gynaecology
Subjects:	ovarian cancer screening CA-125 HE4 ROMA
Online Access:	https://tci-thaijo.org/index.php/tjog/article/download/71820/pdf_213/

Similar Items

Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review
by: Vincent Dochez, et al.
Published: (2019-03-01)

Role of HE4 and ROMA Score in Diagnosis of Ovarian Cancer in Egyptian Women
by: Nahla El-Attar, et al.
Published: (2021-01-01)

Efficacy of HE4, CA125, Risk of Malignancy Index and Risk of Ovarian Malignancy Index to Detect Ovarian Cancer in Women with Presumed Benign Ovarian Tumours: A Prospective, Multicentre Trial
by: Vincent Dochez, et al.
Published: (2019-10-01)

Multi-Marker Longitudinal Algorithms Incorporating HE4 and CA125 in Ovarian Cancer Screening of Postmenopausal Women
by: Aleksandra Gentry-Maharaj, et al.
Published: (2020-07-01)

A multiplex platform for the identification of ovarian cancer biomarkers
by: Kristin L. M. Boylan, et al.
Published: (2017-10-01)

The Performance of HE4 Alone and in Combination with CA125 for the Detection of Ovarian Cancer in an Enriched Primary Care Population
by: Barr, C.E, et al.
Published: (2022)

Biomarkers towards Ovarian Cancer Diagnostics: Present and Future Prospects
by: Meenal Rastogi, et al.

Increased Diagnostic Accuracy of Adnexal Tumors with A Combination of Established Algorithms and Biomarkers
by: Maria Lycke, et al.
Published: (2020-01-01)

The diagnosis and pathological value of combined detection of HE4 and CA125 for patients with ovarian cancer
by: Zheng Li-e, et al.
Published: (2016-01-01)

Overexpression of centromere protein K (CENPK) in ovarian cancer is correlated with poor patient survival and associated with predictive and prognostic relevance
by: Yi-Chao Lee, et al.
Published: (2015-11-01)

HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect
by: Duanyang Liu, et al.
Published: (2018-06-01)

Correlation of Preoperative HE-4 and CA125 with Ovarian Cancer Staging in Ahvaz Imam Khomeni Hospital
by: Fatemeh Cheraghi, et al.
Published: (2020-01-01)

Programmable bio-nano-chip immunosensor for multiplexed detection of ovarian cancer biomarkers
by: Raamanathan, Archana
Published: (2013)

Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer
by: Jorge A. Alegría-Baños, et al.
Published: (2021-07-01)

Subtypes of Ovarian Cancer and Ovarian Cancer Screening
by: Masafumi Koshiyama, et al.
Published: (2017-03-01)

CA125 and Ovarian Cancer: A Comprehensive Review
by: Parsa Charkhchi, et al.
Published: (2020-12-01)

CLINICAL SIGNIFICANCE OF BIOMARKERS IN OVARIAN CANCER, PROSTATE CANCER, COLORECTAL CANCER
by: N. V. Marshutina, et al.
Published: (2016-03-01)

Plasma levels of MMP-7 and TIMP-1 in laboratory diagnostics and differentiation of selected histological types of epithelial ovarian cancers
by: Grażyna Ewa Będkowska, et al.
Published: (2017-06-01)

MALIGNANT OVARIAN TUMORS DIAGNOSTICS DIFFICULTIES
by: S. O. Nikoghosyan, et al.
Published: (2018-08-01)

Clinical efficacy and effect on serum HE4, SMRP, CA125, CA199, B7-H4, TPS of carboplatin combined with paclitaxel for patients with ovarian cancer
by: Qin San, et al.
Published: (2017-07-01)

Postprandial increase in serum CA125 as a surrogate biomarker for early diagnosis of ovarian cancer
by: Zhuowei Gu, et al.
Published: (2018-05-01)

The efficacy of YKL-40 and CA125 as biomarkers for epithelial ovarian cancer
by: L. Zou, et al.
Published: (2010-12-01)

Determination of Serum CA125 and evaluate its efficiency as screening tool For Early Detection of Ovarian Tumors
by: Baghdad Science Journal
Published: (2015-03-01)

Galectin-1 as a predictive biomarker in ovarian cancer
by: Mahak Masoodi, et al.
Published: (2021-09-01)

The role of asymptomatic screening in the detection of recurrent ovarian cancer
by: M.T. Richardson, et al.
Published: (2020-08-01)

Pelvic Peritoneal Tuberculosis Mimicking Stage IV Ovarian Cancer: Case Report
by: Roya Nasiri, et al.
Published: (2008-09-01)

Significance of adding progesterone to the Risk of Ovarian Malignancy Algorithm for early stage ovarian cancer detection in patients with a pelvic mass: A single-center case–control study
by: Kazimierz Pitynski, et al.
Published: (2015-12-01)

Effect of paclitaxel liposome combined with nedaplatin on serum HE4, CA125, CA19-9, AFP, CEA and T lymphocyte subsets in patients with advanced ovarian cancer
by: Su-Yu Zhu, et al.
Published: (2016-08-01)

Assessment of levels of the tumor markers HE4 and CA125 considering staging, grading and histological types of endometrial cancer
by: Nabil Abdalla, et al.
Published: (2016-11-01)

High preoperative blood levels of HE4 predicts poor prognosis in patients with ovarian cancer
by: Kalapotharakos Grigorios, et al.
Published: (2012-08-01)

Best serum biomarker combination for ovarian cancer classification
by: Hye-Jeong Song, et al.
Published: (2018-11-01)

Early identification of recurrence in ovarian cancer: a comparison between the ovarian cancer metastasis index and CA-125 levels
by: Fei Wang, et al.
Published: (2018-11-01)

Clinical Presentation of Pelvic Tuberculosis Imitating Ovarian Malignancy
by: Yun-Ju Huang, et al.
Published: (2004-03-01)

Difficulty in diagnosis and different prognoses between colorectal cancer with ovarian metastasis and advanced ovarian cancer: An empirical study of different surgical adoptions
by: Ko-Chao Lee, et al.
Published: (2017-02-01)

Deciphering the Molecular Nature of Ovarian Cancer Biomarker CA125
by: Peter Hoffmann, et al.
Published: (2012-08-01)

Early clearance of serum HE4 and CA125 in predicting platinum sensitivity and prognosis in epithelial ovarian cancer
by: Yan Rong, et al.
Published: (2021-01-01)

Recommendations and Choices for BRCA Mutation Carriers at Risk for Ovarian Cancer: A Complicated Decision
by: Kelsey E. Lewis, et al.
Published: (2018-02-01)

The Value of Soluble CD146 in the Diagnosis of Ovarian Cancer
by: Ya-qin WANG, et al.
Published: (2016-09-01)

Role of a combined soluble interleukine-2 receptor alpha (sIL-R2α) and CA-125 serum marker assay for detection of ovarian cancer
by: Mačuks Ronalds, et al.
Published: (2011-01-01)

Elevated Serum CA-125 in a Patient with Follicular Lymphoma and a History of Ovarian Cancer
by: Rachna Anand, et al.
Published: (2011-03-01)